Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 12 of 36 / 848 articles
The strongest predictor of youth nicotine use is parental smoking. The most effective prevention strategy is parental cessation. And yet youth prevention programs almost never address parental behavior. The omission is political, not evidence-based.
Across the American South, tobacco festivals persist—celebrations of a crop that is declining, a way of life that is disappearing. The festivals are awkward, contested, and revealing of the complex relationship between communities and the crop that sustained them.
Nicotine policies spread through a process of diffusion—countries adopt policies that have been successful elsewhere. The diffusion can be evidence-based (the UK model spreading to New Zealand) or ideology-based (the WHO's abstinence model spreading to LMICs).
Nicotine users are stigmatized, excluded, and isolated. Online communities—forums, social media groups, advocacy networks—are creating solidarity among a population that has been systematically divided. The solidarity movement is the foundation of consumer power.
Diet affects nicotine craving, withdrawal severity, and cessation success. Specific nutritional strategies—increasing fiber, managing blood sugar, avoiding alcohol—can support the quit attempt. Nutrition is an underutilized tool in smoking cessation.
Nicotine consumers have almost no formal rights: no right to accurate information, no right to product safety, no right to participate in the policy process. A consumer rights framework would transform nicotine governance.
The flavor in your vape is a complex mixture of synthetic and natural aroma chemicals—the same molecules used in food, but inhaled rather than ingested. The flavor chemistry of vaping is a vast, largely uncharted territory of inhalation toxicology.
Every generation born since the 1950s has smoked less than the one before. The generational decline is the most powerful force in tobacco control. Understanding it is essential to predicting the future of nicotine.
Genetic variation in nicotinic receptor genes explains up to 50% of the variance in nicotine dependence. The genetics of addiction are real, clinically relevant, and almost never discussed with smokers. Personalized cessation based on genetics is coming.
Taxi and rideshare drivers smoke at elevated rates. The job—sedentary, stressful, solitary, with long hours and irregular breaks—is a perfect storm for nicotine dependence. The gig economy has a smoking problem, and it's almost entirely unaddressed.
College students use nicotine at significant rates. Almost no university provides adequate cessation support. The gap between the prevalence of nicotine use on campus and the availability of help is a public health failure hiding in plain sight.
Individual tobacco farmers have no bargaining power against the global industry. Cooperatives—farmer-owned organizations that negotiate prices, provide services, and support diversification—could change that. The cooperative model is proven in other crops. It's underused in tobacco.
Nicotine products are subject to a patchwork of safety standards—or none at all. Meaningful safety regulation would include contaminant limits, ingredient disclosure, manufacturing standards, and post-market surveillance. It exists for pharmaceuticals. It doesn't exist for consumer nicotine.
The stories smokers tell about their quit attempts—to themselves and to others—are not just descriptions. They're tools. The recovery narrative can support the quit or sabotage it. Learning to tell a helpful story is part of learning to quit.
Motivation to quit is not constant. It fluctuates—peaking at certain moments (health scares, New Year's resolutions, the birth of a child) and crashing at others. The motivation window is the key concept for timing a quit attempt for maximum success.
Nicotine research is funded by governments, philanthropies, and industry. Each funder has interests. The funding shapes the research—not through crude manipulation, but through the subtle mechanisms of agenda-setting, framing, and selective publication.
Vaping is shedding its countercultural origins and becoming mainstream—a consumer behavior like any other. The normalization is both a public health opportunity (making switching easier for smokers) and a risk (making initiation easier for nonsmokers).
Cannabis policy has moved toward legalization, harm reduction, and consumer rights. Nicotine policy has moved toward restriction, prohibition, and consumer exclusion. Two substances, opposite trajectories. The divergence reveals the role of politics, not evidence, in drug policy.
Nicotine acutely reduces stress—but chronically increases it. The smoker who quits experiences a cortisol spike that drives craving. The nicotine-stress-cortisol feedback loop is a physiological trap that makes quitting feel impossible.
The restaurant industry has one of the highest smoking rates of any profession. The stress, the hours, the culture—all of it drives nicotine use. The industry has begun to change, but the cigarette and the kitchen remain intertwined.
Peer-led cessation programs—where trained adolescent counselors support their peers through quitting—are among the most effective youth nicotine interventions. They leverage the most powerful force in adolescent life: the desire to be understood by someone like you.
Indigenous communities have used tobacco ceremonially for millennia. The commercial cigarette industry has exploited that tradition. The tension between sacred use and commercial exploitation is at the heart of Indigenous tobacco policy.
Three years of data from jurisdictions that implemented flavor bans: youth vaping declined, adult smoking may have increased, and the net public health effect remains uncertain. The flavor ban experiment is producing results. The results are more nuanced than either side expected.
Digital cessation tools—apps, chatbots, telehealth—are transforming how people quit smoking. They're also widening the gap between the digitally connected and the digitally excluded. The digital divide in cessation is the newest dimension of health inequality.
Products
Select a product to view details, highlights, and technical specifications.
